Maximilian Knapp

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Systemic Sclerosis

Inflammatory Response

Diffuse Large B Cell Lymphoma

Top Venues

Hepatology communications

Clinical & translational immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Christoph Schultheiß, Edith Willscher, Lisa Paschold, Christin Ackermann, Moritz Escher, Rebekka Scholz, Maximilian Knapp, Jana Lützkendorf, Lutz Peter Müller, Julian Schulze Zur-Wiesch, Mascha Binder
B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection. Hepatology communications 8 (8) (2024)
Christoph Schultheiß, Edith Willscher, Lisa Paschold, Christin Ackermann, Moritz Escher, Rebekka Scholz, Maximilian Knapp, Jana Lützkendorf, Lutz Peter Müller, Julian Schulze Zur-Wiesch, Mascha Binder
B cells expressing mutated IGHV1-69-encoded antigen receptors related to virus neutralization show lymphoma-like transcriptomes in patients with chronic HCV infection. Hepatology communications 8 (8) (2024)
Hendrik Karsten, Leon Cords, Tim Westphal, Maximilian Knapp, Thomas Theo Brehm, Lennart Hermanussen, Till Frederik Omansen, Stefan Schmiedel, Robin Woost, Vanessa Ditt, Sven Peine, Marc Lütgehetmann, Samuel Huber, Christin Ackermann, Melanie Wittner, Marylyn Martina Addo, Alessandro Sette, John Sidney, Julian Schulze Zur-Wiesch
High-resolution analysis of individual spike peptide-specific CD4 + T-cell responses in vaccine recipients and COVID-19 patients. Clinical & translational immunology 11 (8) (2022)
Leon Cords, Maximilian Knapp, Robin Woost, Sophia Schulte, Silke Kummer, Christin Ackermann, Claudia Beisel, Sven Peine, Alexandra Märta Johansson, William Wai-Hung Kwok, Thomas Günther, Nicole Fischer, Melanie Wittner, Marylyn Martina Addo, Samuel Huber, Julian Schulze Zur-Wiesch
High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4 + T-Cells in an Anti-CD20-Treated Patient with Prolonged COVID-19. Viruses 14 (6) (2022)